CompaniesConvergence Pharmaceuticals

Convergence Pharmaceuticals

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (2)

Total Trials

2

As Lead Sponsor

2

As Collaborator

0

Total Enrollment

229

By Phase

PHASE2: 2

By Status

COMPLETED: 2

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2012

2013

2014

2015

Today

Hover over trial bars to see details

Recent Trials

NCT01893125Lead Sponsor

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Diabetic Peripheral Neuropathy

PHASE2Completed

126 participants

Started: Aug 31, 2013 · Completed: Sep 30, 2014

NCT01848730Lead Sponsor

Efficacy and Safety of CNV2197944 Versus Placebo in Patients With Post-herpetic Neuralgia

PHASE2Completed

103 participants

Started: Apr 30, 2013 · Completed: May 31, 2014